Register by November 2 to get the lowest available rates for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
buff.ly/ZJJqL8Y
#SABCS26

Charles M. Perou, PhD, will receive the 2026 William L. McGuire Memorial Lecture Award at #SABCS26 in recognition of his pioneering research in cancer genomics and breast cancer biology. He will deliver his award lecture on Thursday, Dec. 10, at 9 AM CT. https://bit.ly/4j8Xd70

Individual Housing Deadline: November 30—
Make your hotel reservations for #SABCS26 now and join us in San Antonio December 8-11. Learn more:
buff.ly/miRnSAs

Could vaccines help prevent breast cancer?

At #SABCS26, hear the latest research on harnessing the immune system for prevention, including vaccine strategies for individuals at increased risk.

Join the conversation. Register at sabcs.org.

Getting ready for #SABCS26? Consider simultaneous publication with #JCO Journals. Send an inquiry before October 8 for consideration.📅

Learn more at: https://bit.ly/4hji6tz

“The science we bring forward is at the heart of this symposium.”
Two days remain to submit late-breaking abstracts to #SABCS26. Program Director Kate Lathrop, MD, discusses how researchers can still contribute to the global scientific conversation in SABCS Meeting News: https://bit.ly/4xIVBEA

Today is the last day to get the lowest registration rates for #SABCS26. Register now and join the global breast cancer community in San Antonio, Dec. 8–11. Visit SABCS.org to register.

Register by September 25 to get the lowest rates for #SABCS26 and join the breast cancer community in San Antonio December 8-11. Learn more:
buff.ly/3pDrDf2

Register by September 25 to get the lowest rates for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
buff.ly/ZJJqL8Y
#SABCS26

When should endocrine therapy change for patients with HR-positive metastatic breast cancer? Drs. Virginia Kaklamani, Erika Hamilton and Komal Jhaveri discuss SERENA-4, SERENA-6 and imlunestrant + abemaciclib in this SABCS Snippet. #SABCS26. Watch: https://youtu.be/-wsO5LQXJgE

Don’t miss the latest science that is changing how we think about early breast cancer treatment—from cryoablation and precision radiation to endocrine therapy.
View the #SABCS26 program and register by September 25 for the lowest rates: sabcs.org

Make your hotel reservations by November 30 to ensure the lowest available rates for #SABCS26. Learn more:
buff.ly/miRnSAs

The world’s largest breast cancer symposium is back for its 49th year. Join the global breast cancer research community in San Antonio for #SABCS26, December 8–11. Register by September 25 to get the lowest rates. Learn more: sabcs.org

104 countries. More than 11,000 attendees. One global breast cancer community driving progress in research and care.

#SABCS26 returns to San Antonio December 8–11. Tell us where you’re coming from in the comments.

Register by September 25 to get the lowest rates for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
buff.ly/ZJJqL8Y
#SABCS26

Register by September 25 to get the lowest rates for #SABCS26 (December 8-11). Learn more:
buff.ly/3pDrDf2

Camizestrant received accelerated FDA approval Friday. At #SABCS25, François-Clément Bidard, MD, presented updated Phase 3 SERENA-6 results showing how ctDNA can detect treatment resistance before disease progression. What will we see next? Join us at #SABCS26, Dec. 8–11. https://bit.ly/463weSl